Pierre Fabre Pharmaceuticals – Product Catalog (A–Z)
Busilvex → Generic: busulfan (IV infusion) → Indication: Conditioning regimen before hematopoietic stem cell transplantation (CML, AML, lymphomas) → Dose: Injection concentrate 6 mg/mL
Javlor → Generic: vinflunine ditartrate → Indication: Advanced or metastatic urothelial carcinoma (bladder cancer) → Dose: IV infusion vials 25 mg/mL
Navelbine → Generic: vinorelbine tartrate → Indication: Non-small cell lung cancer (NSCLC), advanced breast cancer → Dose: Soft capsules 20 mg, 30 mg; IV solution vials 10 mg/mL
Picato (withdrawn in EU/US 2020) → Generic: ingenol mebutate → Indication: Actinic keratosis (dermatology) → Dose: Topical gel 150 mcg/g, 500 mcg/g (discontinued for safety reasons)
Trisenox (EU co-marketed) → Generic: arsenic trioxide → Indication: Acute promyelocytic leukemia (APL) → Dose: IV infusion 1 mg/mL
Pierre Fabre OncoSupport → Generic: nutritional and supportive oncology care products → Indication: Dietary/nutrition support in oncology → Dose: Oral nutritional supplements (varied formulations)
No comments:
Post a Comment